rhodamine 123 has been researched along with dihydroptychantol a in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, J; Li, SJ; Li, X; Lou, HX; Shi, YQ; Sun, B; Yuan, HQ; Zhu, CJ | 1 |
1 other study(ies) available for rhodamine 123 and dihydroptychantol a
Article | Year |
---|---|
Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Flow Cytometry; Gene Expression; Hepatophyta; Humans; Leukemia, Myeloid; Phenyl Ethers; Rhodamine 123; RNA, Messenger; Stilbenes; Structure-Activity Relationship | 2009 |